Xuejiao Song
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Novel FGFR Inhibitor Combined with Radiotherapy Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death Improving Anti-Tumor Activity.
Journal: Journal of medicinal chemistry
Published: December 30, 2025
Microbiota and mycobiota in bronchoalveolar lavage fluid of silicosis patients.
Journal: Journal of occupational medicine and toxicology (London, England)
Published: April 14, 2023
A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity.
Journal: Heliyon
Published: December 14, 2022
Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.
Journal: Biochemical pharmacology
Published: November 08, 2022
Brain Proteome-Wide and Transcriptome-Wide Asso-ciation Studies, Bayesian Colocalization, and Mendelian Randomization Analyses Reveal Causal Genes of Parkinson's Disease.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: September 01, 2022
Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.
Journal: Scientific reports
Published: June 28, 2022
Copper-Catalyzed Ring-Opening Defluoroborylation of gem-Difluorinated Cyclobutenes: A General Route to Bifunctional 1,3-Dienes and Their Applications.
Journal: Organic letters
Published: March 03, 2022
Application of the Tumor Site Recognizable and Dual-Responsive Nanoparticles for Combinational Treatment of the Drug-Resistant Colorectal Cancer.
Journal: Pharmaceutical research
Published: January 18, 2020
D-4F, an apolipoprotein A-I mimetic, suppresses IL-4 induced macrophage alternative activation and pro-fibrotic TGF-β1 expression.
Journal: Pharmaceutical biology
Published: July 24, 2019
Novel Dual BET and PLK1 Inhibitor WNY0824 Exerts Potent Antitumor Effects in CRPC by Inhibiting Transcription Factor Function and Inducing Mitotic Abnormality.
Journal: Molecular cancer therapeutics
Published: June 05, 2019
Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis.
Journal: European journal of medicinal chemistry
Published: April 22, 2019
Last Updated: 09/26/2026